[{"AccountsPayableCurrent_0_Q2_USD":195000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":291000.0,"OtherLiabilitiesCurrent_0_Q2_USD":776000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":82000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":413147000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1_Q2_USD":12152000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":177148000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":98190000.0,"PaymentsOfDividendsCommonStock_2_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-29000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-35000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":144645000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":78028000.0,"IncreaseDecreaseInDeferredLeasingFees_2_Q2_USD":135000.0,"EarningsPerShareDiluted_2_Q2_USD":1.27,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_1_Q2_shares":12189000.0,"EarningsPerShareDiluted_1_Q2_USD":0.69,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":142281000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":240984000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_0_Q2_USD":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0_Q2_USD":192500000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":6921000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":35823000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":118348000.0,"IncreaseDecreaseInInterestPayableNet_2_Q2_USD":0.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-35000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":34896000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":21381000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":142252000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":76809000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1260017000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":76844000.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2_Q2_shares":12189000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":163000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":336000.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":68613000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":157624000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":78946000.0,"PaymentsToMinorityShareholders_2_Q2_USD":27962000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":12943000.0,"PaymentsToAcquireLongtermInvestments_2_Q2_USD":60000000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":72000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-6000.0,"NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_1_Q2_USD":350000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":60000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":123000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":109000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":292000.0,"InvestmentIncomeNet_2_Q2_USD":1460000.0,"InvestmentIncomeNet_1_Q2_USD":158000.0,"InterestOnConvertibleDebtNetOfTax_2_Q2_USD":2364000.0,"InterestOnConvertibleDebtNetOfTax_1_Q2_USD":1184000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":32000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":58000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":375000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":4110000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":6000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-15000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":382465000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":3999000.0,"CapitalizedContractCostNet_0_Q2_USD":132164000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":135051000.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q2_USD":52254000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"IncreaseDecreaseInDueFromRelatedPartiesCurrent_2_Q2_USD":2975000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":382471000.0,"WeightedAverageNumberOfSharesIssuedBasic_1_Q2_shares":101324000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":101280000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":180000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"StockholdersEquity_0_Q2_USD":456907000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-804123000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":37000.0,"ProfitLoss_2_Q2_USD":177177000.0,"ProfitLoss_1_Q2_USD":98225000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":422000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":645000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":13000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":153275000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":9044000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-27268000.0,"LiabilitiesCurrent_0_Q2_USD":5414000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":879619000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-317000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":35823000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":19891000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":213000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":118116000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":5159000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":2596000.0,"DueFromRelatedPartiesCurrent_0_Q2_USD":82402000.0,"CommonStockValue_0_Q2_USD":1015000.0,"CommonStockSharesOutstanding_0_Q2_shares":101392000.0,"CommonStockSharesIssued_0_Q2_shares":101392000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":413147000.0,"AssetsCurrent_0_Q2_USD":500193000.0,"Assets_0_Q2_USD":879619000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-2000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":185000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":433484000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"OtherAssetsNoncurrent_0_Q2_USD":264000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":34896000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":21381000.0,"MinorityInterest_0_Q2_USD":35905000.0,"LongTermDebtNoncurrent_0_Q2_USD":381230000.0,"EarningsPerShareBasic_2_Q2_USD":1.4,"EarningsPerShareBasic_1_Q2_USD":0.76,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":492812000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":98000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":30000.0,"GainLossOnInvestments_2_Q2_USD":68613000.0,"GainLossOnInvestments_1_Q2_USD":46698000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.17,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":113527000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":113545000.0,"ShareBasedCompensation_2_Q2_USD":810000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":559000.0,"InterestExpense_1_Q2_USD":4561000.0,"InterestExpense_2_Q2_USD":9077000.0,"InterestPaidNet_2_Q2_USD":4967000.0,"InterestPayableCurrent_0_Q2_USD":4152000.0,"OperatingExpenses_1_Q2_USD":3155000.0,"OperatingExpenses_2_Q2_USD":5718000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":101324000.0,"OperatingIncomeLoss_1_Q2_USD":75791000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"PreferredStockSharesAuthorized_0_Q2_shares":230000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"ResearchAndDevelopmentExpense_1_Q2_USD":559000.0,"OperatingIncomeLoss_2_Q2_USD":151906000.0,"WeightedAverageNumberOfSharesIssuedBasic_2_Q2_shares":101280000.0,"Ticker":"INVA","CIK":"1080014","name":"INNOVIVA, INC.","OfficialName":"Innoviva Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1257937389.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200729"}]